Webinar Series
The Strengths and Weaknesses of HbA1c in the Diagnosis of Diabetes

Dave Koch

with Dave Koch, PhD, DABCC, FACB Director, Clinical Chemistry, Toxicology, and POCT, Grady Memorial Hospital Professor, Department of Pathology and Lab Medicine, Emory University School of Medicine, Atlanta, GA

Immediate access to the recorded webinar

In commemoration of World Diabetes Day, on November 14, Bio-Rad is pleased to invite you to the next webinar in our Hemoglobin Testing Series.

This presentation will cover the strengths, weaknesses and practical details of HbA1c in the diagnosis of diabetes. The objectives of this presentation include:

  1. How HbA1c is useful in diagnosing and monitoring diabetes
  2. How HbA1c is measured
  3. How hemoglobin variants in the patient sample and other patient characteristics might impact the HbA1c result that is obtained
Dave Koch

Dave Koch, PhD,
DABCC, FACB Director, Clinical Chemistry, Toxicology, and POCT, Grady Memorial Hospital Professor, Department of Pathology and Lab Medicine, Emory University School of Medicine, Atlanta, GA

Dr. Koch is the director of clinical chemistry at Grady Memorial Hospital and a professor at Emory University School of Medicine in the department of Pathology and Laboratory Medicine in Atlanta, Georgia. He earned a PhD in Analytical Chemistry from Purdue University. He is also the author of numerous scientific papers and was the former president of AACC.